has been successfully separated from the n-BuOH extracts of Trillium tschonoskii Maxim and is able to induce cytotoxicity to some types cancer cells. The present study aimed to investigate how this novel saponinin duces cytotoxicity in malignant sarcoma cells and to clarify its molecular mechanisms of action. It was determined this steroidal saponin induced the apoptosis in Rh1 cells and activated caspase-3 and caspase-9. Additionally, it disrupted the mitochondrial membrane potential and altered the expression of bax and bcl-2. Thus, the results of present study identified that an anticancer saponin isolated from Trillium tschonoskii Maxim may be developed as a potential novel therapeutic strategy to treat certain types of cancer, including lung cancer and lung sarcoma.
Introduction
Successful treatment with chemotherapeutic agents is largely dependent on their ability to trigger cell apoptosisin tumor cells (1) . Many studies demonstrate that certain phytochemicals found in medicinal plants exert anti-tumor activity by inducing apoptosis in cancer cells (2, 3) . Trillium tschonoskii Maxim, also named 'a pearl on head' , mainly distributed in mid-western China, has been in folk used to cure headache, hypertension, neurasthenia, giddiness, cancer, eliminating carbuncles and relieving the pains for at least one thousand years (4, 5) . A Initial studies have demonstrated that variety of bioactive compounds including steroidal saponins and steroidal glycosides have been identified in plants belonging to the Trillium genus, such as Trillium erectum (6, 7) , Trillium kamtschaticum (8, 9) and Trillium tschonoskii Maxim (10) . Active chemical components, including saponin polysaccharide, derived from Trillium tschonoskii Maxim exhibit anti-bacterial and anti-cancer effects (11, 12) . In a previous study (12) , it was also determined that pennogenin 3-O-α-L-rhamnopyranosyl-(1→2) [α-L-rhamnopyranosyl-(1→4)]-β-D-glucopyranoside (TTB2) suppressed the proliferation of the Ewing sarcoma cell line and arrested cells in the G2/M and S phases of the cell cycle in a dose-and time-dependent fashion (12) . Furthermore, the phosphorylation of extracellular signal-regulated kinase which serves an important role in tumorigenesis (12) . However, it remains unclear which types of cancer cells TTB2 induces death induced by TTB2. In a previous study, it was demonstrated that TTB2, a steroidal saponin from the n-butanol extracts of Trillium tschonoskii Maxim, inhibits cell growth, induces apoptosis of Ewing sarcoma cells (12) . Additionally, the present study indicated that TTB2 could trigger apoptosis protein cascades, decrease the mitochondrial membrane potential (MMP) and alter the expression of bax and bcl-2. The results suggest that TTB2 may execute its anticancer activity by inducing apoptosis and may be developed as a new class of chemotherapy drug.
Materials and methods
Reagents. Bovine serum albumin (BSA), the Annexin V-FITC Apoptosis Test kit and chloromethyl-X-rosamine (CMX-Ros) were all obtained from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany was extracted and isolated from Trillium tschonoskii Maxim following a previously published method (12) . The TTB22 mg) powder was dissolved in deionized water 60 µl). To prevent cell contamination, the TTB2 stock solution was filtered with 0.22 um-sized filtering membrane and separated into individual aliquots, which were kept at -20˚C until further use.
Cell culture. Rh1 cells, derived from mesenchymal tissue, are a type of human rhabdomyosarcoma cell, and were provided by St. Jude Children's Research Hospital, Memphis, TN, USA were cultured in antibiotic-free RPMI-1640 medium containing 10% FBS at 37˚C and 5% CO 2 for 24 h as demonstrated in a previous study (12) .
Annexin V-FITC/PI cytometric analysis. To determine the mechanism by which TTB2-induced death of Rh1 cells, Annexin V and PI double staining were analyzed by Flow Cytometry (FCM, BD Biosciences, Franklin Lakes, NJ, USA). Rh1 cells (2x10 5 ) were seeded and incubated for 24 h at 37˚C. RPMI medium was replaced with an equal volume of fresh medium containing different concentrations (5 and 10 µM) of TTB2. PBS was used as the negative control. Following supplementation with TTB2 for 24 h all the cells containing attached and nonattached cell were collected and washed twice with PBS. Subsequently, the harvested cells were added to 400 µl 1x binding buffer (obtained from the Annexin V/PI staining kit), 5 µl Annexin V and 10 µl PI staining, and kept in the dark for 15 min. Apoptotic, necrotic and mechanically damaged cells were determined using flow cytometry software (BD FACSuite™; v1.0.5; BD Biosciences) with the single beam at a 488 nm wave length.
Assessment of mitochondrial membrane potential. CMX-Ros (cat. no. 40741ES50; Shanghai yisheng Biotechnology Co., Ltd., Qingdao, China) was used to analyze MMP. Rh1 cells (2x10 5 ) for each sample were seeded and incubated for 24 h at 37˚C. RPMI medium was replaced with an equal volume of fresh medium containing different concentrations of TTB2 (5 and 10 µM). PBS was used as the negative control. Following supplementation with TTB2 for 24 h, all living cells were harvested and washed twice with PBS. MitoTracker Red CMXRos powder (50 µg; cat. no. 40741ES50; Shanghai Yisheng Biotechnology Co., Ltd.) was dissolved in 94 µl of dimethylsulfoxide to be used as a storage solution (1 mM Mitotracker Red CMXRos), which was stored at -20˚C. Storage solution (1 µl) was eventually diluted in 2 ml PBS, which became the working solution with a final concentration of 500 nM CMX-Ros. Cells were resuspended in 100 µl of PBS containing 500 nM MitoTrackerCMX-Ros and incubated for 45 min at 37˚C. Cells were washed with PBS and resuspended in PBS supplemented with 0.2% BSA and then placed on ice prior to flow cytometric (FACSVerse; BD Biosciences, Franklin Lakes, NJ, USA) analysis with a single excitation beam at 488 nm. MitoTracker Red CMXRos, an oxidized red fluorescent dye, travel across the cell membrane and gather in active mitochondria. Thus, once the mitochondria were stained, the probe remained within the cell. The stained cell was then directly analyzed using flow cytometry. Results were analyzed using BD FACSuite™ software v1.0.5 (cat. no. 657658; BD Biosciences).
Western blot analysis. Analysis of relative protein expression analysis was conducted by western blot method. Briefly, Rh1 cells (2x10 5 per well) were seeded in 6-well plates and cultured until an 80% confluence was reached. Cells were then treated with indicated concentrations (0, 5 µM) of TTB2 for 24 h at 37˚C and then harvested and washed with cold PBS. Cell pellets were lysed in 40 µl lysis buffer (20 mM HEPES/NaOH, pH 7.5, 250 mM sucrose, 10 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, protease inhibitor cocktail (cat. no. S8820-2TAB; Sigma-Aldrich; Merck KGaA) for 20 min on ice. The lysis solution was centrifuged at 25,000 x g for 10 min at 4˚C and protein contents in the supernatant were measured using a DC protein assay kit (cat. no. 500-0119; Bio-Rad, Laboratories, Inc., Hercules, CA, USA). Proteins (25 µg) were separated using 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Membranes were then blocked with 5% skimmed milk dissolved in Tris-buffered saline (TBS; 2 mM Tris-HCl, 140 mM NaCl; pH 7.6) with Tween-20 for 2 h at room temperature. Following five washes (each, 5 min), membranes were incubated with corresponding antibodies against cytochrome c (cat. no. sc-65396), bax (cat. no. sc-7480), bcl-2 (cat. no. sc-7382), caspase-3 (cat. no. 9661), caspase 9 (cat. no. 7237) and tubulin (cat. no. sc-8035; each 1:200) at 4˚C overnight. Following five washes with TBS with Tween-20, membranes were incubated with corresponding horseradish peroxidase-conjugated secondary antibodies obtained from Santa Cruz Biotechnology, Inc. (1:5,000) for 50 min at room temperature. The bands were visualized using the ECL chemiluminescence system (Bioshine ChemiQ 4800 mini; Hangzhou Yaxu Biotechnology Co., Ltd., Shanghai of China) and subjected to densitometric analysis using Image-J2 software (National Institutes of Health, Bethesda, MD, USA) to semi-quantify the protein expression of TTB2 treated groups against the control group (tubulin).
Statistical analysis. All data were presented as mean ± standard deviation. Data were processed with the SPSS 19.0 for Windows software package (IBM Corp., Armonk, NY, USA). One-way analysis of variance was used for statistical evaluations. Multiple comparisons between the groups were performed using Newman-Keuls test. P<0.05 was considered to indicate a significant difference.
Results
Chemical structure of TTB2. The structure of TTB2is presented in Fig. 1 . Its full chemical name is pennogenin
TTB2 induces apoptosis in Rh1 cells.
To identify the nature of cell death, the early marker of apoptosis Annexin V and the dead cell marker propidium iodide were used to evaluate the cytotoxic effects of TTB2 on Rh1 cells. As presented in Fig. 2 , following treatment with different concentrations of TTB2, the numbers of early apoptotic and late apoptotic/necrotic cells were determined. Treatment with 5 and 10 µM TTB2 for 24 h resulted in 45.48 and 82.65% of Rh1 cells undergoing early apoptosis, respectively compared with 2.44% of cells in the control ( Fig. 2A-C) . These results indicate that the antitumor action of TTB2 is associated with the induction of potent apoptosis in a dose-dependent manner (Fig. 2D) .
TTB2 treatment affects mitochondrial function.
To determine whether changes in the MMP were implicated in the apoptosis induced by TTB2, cells were stained with CMX-Ros and analyzed using flow cytometry. Fig. 3 demonstrates that, compared with the control, treatment with 5 and 10 µM TTB2 significantly decreased the MMP in Rh1 cells (P<0.05; Fig. 3A) . Additionally, the release of cytochrome c following TTB2 treatment was evaluated using western blotting. The results demonstrated that there was a significant increase in cytochrome c levels following treatment with 5 µM TTB2 (P<0.05; Fig. 3B and D) . To determine the molecular mechanisms of apoptosis induced by TTB2, the levels of the anti-apoptotic protein bcl-2 and the pro-apoptotic protein bax were measured. Levels of bax significantly increased and levels of bcl-2 significantly decreased following treatment with TTB2 (both P<0.05; Fig. 3D ). These results indicate that TTB2 induces apoptosis in Rh1 cells via the intrinsic mitochondrial pathway.
TTB2 treatment affects the levels of apoptosis proteins.
Western blotting was used to determine whether TTB2 treatment altered the levels of the cleaved apoptotic proteins caspases-3 and -9. As presented in Fig. 3C and D, it was determined that TTB2 treatment activated caspases-3 and -9. Compared with controls, TTB2 treatment significantly increased levels of cleaved caspases-3 and -9 (P<0.05; Fig. 3D ).
Discussion
Cancer is a type of disease with poor patient prognosis. The incidence of most types of cancer continues to increase annually and the mortality rates generally remain high (13) . Most tumors develop drug resistant following exposure to drug over a prolonged period of time (14, 15) . Thus, it's imperative to develop novel medicines to reduce the morbidity and mortality of cancer. Steroidal saponins have been isolated from many types of medicinal plants. They have numerous pharmacological functions and exhibit biological activities, including cytotoxic, antifungal, enzyme-inhibitory, anti-inflammatory and antithrombotic activity (16) (17) (18) . Compound TTB2, penno-
extracted from Trillium kamtschaticum (9) and Paris polyphylla var. Yunnanensis (19) . However, there have been few studies investigating its bioactivity (9) . It has been demonstrated that some pennogenin steroid analogues from other plants exerted different bioactivity (19) 
Paris polyphylla var. yunnanensis protects the stomach from damage induced by ethanol and indomethacin (20) . Furthermore, certain analogues including pennogenin
Paris vietnamensis (22) were induce cytotoxicityin cancer cells. And we ever reported that TTB2 from the rhizomes of Trillium tschonoskii Maxim has the cytotoxicity on the Ewing sarcoma cell line and attenuate the cells in the G2/M and S phases (12) .
When cells undergo apoptosis, phosphatidyl serine shifts from the inner side of the plasma membrane to its outer leaflet (23) . Under this circumstance phosphatidyl serine is able to bind to Annexin V (24) and this property means that it is relatively easy to investigate apoptosis in all cells. The current study demonstrated the TTB2 potently induced apoptosis in Rh1 cells in a dose-dependent manner. Indeed, to the best of our knowledge, the current study is the first indicate that TTB2, a pennogenin steroid isolated from Trillium tschonoskii Maxim, could induce cancer cell line apoptosis. Mitochondrial dysfunction may trigger intrinsic pathway of apoptosis and is associated with numerous cell processes (25, 26) . It has been reported that some stimuli such as radiation and toxins may stimulate the opening of mitochondrial permeability transition pores which then increase the permeability of the mitochondrial inner membrane, leading to disruption of ionic homeostasis, the collapse of MMP and cytochrome c release (27) . Furthermore, procaspase-9 and released cytochrome c may stimulate production of the apoptosome that drives the activation of caspase-3 and eventually leads to the apoptosis (28) . When cells are exposed to pathogens or mild inflammatory factors, the pro-apoptotic member bax shifts from the cytosol to mitochondrial outer membrane, which breaks the mitochondrial stability and facilitates the mitochondrial permeability transition and release of cytochrome c (29) . And anti-apoptotic protein bcl-2 is primarily located on mitochondrial outer membranes where it takes part in blocking membrane permeabilization (30) . The results of the current study indicate that these molecular mechanisms involved in TTB2-treated Rh1 cells. Western blot analysis demonstrated that treatment with TTB2 provoked a marked decrease in the expression of bcl-2 and an increase in bax expression in TTB2-treated cells. Additionally, it was determined that TTB2 elevated the level of cytosolic cytochrome c, which serves a critical role in the formation of apoptosome as well as the caspase activation cascades that ultimately activates caspase-3. Combined with the results of previous study, which indicated that the TTB2inhibits the phosphorylation of extracellular signal-regulated kinase and promotes cell cycle arrest (12) , the present study determined the procedures that have been closely implicated in the apoptosis of Rh1 cells caused by TTB2.
In conclusion, the results of the current study identified that the effects of TTB2 on Rh1 cells rely onTTB2-induced apoptosis, which is closely associated with mitochondrial signaling pathways. The current study suggested that TTB2 isolated from Trillium tschonoskii Maxim may be developed as novel anti-cancer drugs in the future.
